Extrapulmonary Small Cell Gastric Carcinoma:A Case Report and Review of the Literature

Abstract

Extrapulmonary anaplastic small cell tumours (EPSCC) of the gastrointestinal tract are generally aggressive neoplasms with a poor prognosis. Recent work has demonstrated that EPSCC may be sensitive to the chemotherapeutic regimens employed to treat small cell lung cancer.In this report we present the case of a patient with a primary anaplastic small cell gastric carcinoma treated with combination chemotherapy. Plasma calcitonin, somatostatin, gastrin releasing peptide, total enolase and non-muscle creatine kinase levels were measured before and, if elevated, after completion of induction chemotherapy. Doxorubicin, cyclophosphamide and etoposide treatment resulted in a complete remission which lasted for 11 months. Calcitonin levels, elevated prior to treatment, fell to within the normal range following completion of induction therapy. Extrapulmonary gastric small cell cancer is sensitive to cytotoxic chemotherapy. Like small cell lung cancer, these tumours may produce plasma/serum markers which may be useful in monitoring response to therapy.Case report. A 54-year-old man presented with a 3-month history of severe epigastric pain in October 1992. The pain was waking the patient from his sleep, was aggravated by moving and eased by vomiting. The symptoms were associated with a weight loss of 16 kg. There was no history of dysphagia. He had stopped smoking cigarettes 14 years earlier. Physical examination revealed exquisite tenderness in the epigastrium. On the day following admission to hospital he had an episode of haematemesis.At oesophago-gastroscopy examination a protruberant ulcerating lesion was noted in the gastric cardia below the oesophagogastric junction. The oesophegus appeared normal. Biopsies of the gastric mass (Figs la and b) revealed an infiltrating neoplasm composed of mitotically active small cells with hyperchromatic nuclei, inconspicuous nucleoli and scanty cytoplasm resembling small cell carcinoma of the lung. The cells were uniformly negative for common leukocyte antigen and weakly positive for keratin and neuron-specific enolase. Further biopsies were taken of the gastric antrum which revealed helicobacter pylori positive antral gastritis.A full blood count, renal, liver and bone biochemistry were within normal limits. Bone marrow aspirate and bone biopsy showed no evidence of malignant infiltration. Radiology included a CXR and CT scan of the thorax, a CT brain scan and isotope bone scan all of which were normal. A CT examination of the abdomen revealed evidence of a tumour at the cardia of the stomach with suhmucosal extension to involve the lower oesophagus. A subsequent barium swallow confirmed these findings. A radiolabelled somatostatin analogue scan, using "'In-[DTPA-DPhe'l-octreotide as the radioligand, failed to localise either the primary tumour or show evidence of metastases.Plasma and serum samples were obtained for analysis for the presence of a number of markers. Gastrin releasing peptide, somatostatin, total enolase and non-muscle creatine kinase levels were within normal lim...

Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases

“…The median survival was described in the range of 6 -12 months or of several weeks, for treated or untreated patients, respectively (Redman and Pazdur, 1987;Wick et al, 1987;O'Byrne et al, 1997). In our study, all but two patients were treated; the median survival was 11 months and 2-year survival was 23%.…”

Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy

“…Concerning treatment, because of the tumor's aggressive biological characteristics, intensive chemotherapy, with or without operation, is recommended for gastric ECC at any stage [44]. Previously, several chemotherapeutic menus have been employed for gastric ECCs, but their effectiveness has been shown in only a few patients [32,46,55]. Sakai et al [32] showed complete remission in a 31-year-old man with gastric ECC with multiple bone metastasis (case 29 in Table 1), with seven cycles of chemotherapy consisting of cisplatin (CDDP), etoposide, cyclophosphamide, epirubicin, and vincristine, followed by high-dose chemotherapy and peripheral blood cell transplantation.…”

Extrapulmonary small cell carcinoma of lymph node: Pooled analysis of all reported cases

“…Role of surgical resection in SCLC is limited with treatment being primarily combined chemoradiation [54] . However, SCC has also been described in various other parts of the body including the gastro-intestinal tract, male and female genital tract, musculoskeletal system and others [5,15,[55][56][57] . Extrapulmonary SCLC, especially in the lymph nodes, is an extremely rare entity.…”